Used as an intermediate in the synthesis of protease inhibitors, particularly in the development of antiviral agents. Its structure supports selective binding to enzyme active sites, making it valuable in drug design for diseases like hepatitis C and other viral infections. The thiol group enables conjugation or cyclization reactions, while the nitrobenzyl moiety can act as a photolabile protecting group in controlled release systems. Commonly employed in medicinal chemistry for optimizing pharmacokinetic properties and enhancing target specificity.